Ramipril
Who holds supplier records for Ramipril? 17 organisations hold a current record for Ramipril: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (11), China (2), Germany (1), Hungary (1) and 2 other countries (2).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Ramipril: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ramipril
Reading the evidence
- 17 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
11 of the 17 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 10 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (17)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Ramipril. Country is the organisation's recorded country, not necessarily the manufacturing site.
- AARTI PHARMALABS LIMITEDIndiaCEPActive DMF 19714 · latest filing Aug 2006
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 17570 · latest filing Jul 2004
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 17033 · latest filing Dec 2003
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 16193 · latest filing Oct 2002
- EUROAPI GERMANY GMBHGermanyCEP Company GMP cert on recordActive DMF 15208, 37506 · latest filing Dec 2022
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 18338 · latest filing May 2004
- Neuland Laboratories LimitedIndiaCEPActive DMF 16647 · latest filing Jun 2003
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 24650 · latest filing Jan 2011
- Apotex Pharmachem India Pvt. Ltd.IndiaActive DMF 20713 · latest filing Jul 2007
- Lupin LimitedIndia Company GMP cert on recordActive DMF 17956, 18024 · latest filing Mar 2005
- UNIMARK REMEDIES LTDIndiaActive DMF 19522 · latest filing Jun 2006
- HungaryCEP Company GMP cert on record
- SpainCEP
- MELODY HEALTHCARE PVT LTDIndiaCEPInactive DMF 23885 · latest filing Apr 2010
- IndiaCEP Company GMP cert on record
- CzechiaCEP Company GMP cert on record
- Zhejiang Changming Pharmaceutical Co.,LtdChinaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (14)
Certificates of Suitability on the EDQM register for Ramipril, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 23 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZENTIVA K.S. Prague | CZ | CEP 2024-053 - Rev 00 Ramipril | Jun 2026 | Inspected Jun 2026 Czechia |
| EGIS Pharmaceuticals PLC Budapest | HU | CEP 2020-284 - Rev 02 Ramipril, RMP | Dec 2025 | Inspected Nov 2025 Hungary |
| NEULAND LABORATORIES LIMITED Hyderabad | IN | CEP 2003-219 - Rev 08 Ramipril | May 2025 | — |
| ZHEJIANG CHANGMING PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2010-176 - Rev 01 Ramipril | Mar 2025 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2021-281 - Rev 01 Ramipril, Process-II | Mar 2025 | — |
| AARTI PHARMALABS LIMITED Mulund (W), Mumbai | IN | CEP 2009-083 - Rev 06 Ramipril, Grade A | Mar 2025 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2003-050 - Rev 10 Ramipril | Mar 2024 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2004-222 - Rev 05 Ramipril | Nov 2023 | — |
| EUROAPI GERMANY GmbH Frankfurt am Main | DE | R1-CEP 2001-297 - Rev 07 Ramipril | Dec 2021 | — |
| MELODY HEALTHCARE PVT. LTD. Boisar | IN | R1-CEP 2008-220 - Rev 03 Ramipril | Nov 2019 | — |
| Farmhispania, S.A. Montmeló | ES | R1-CEP 2004-224 - Rev 02 Ramipril | Oct 2019 | — |
| CIPLA LIMITED Mumbai | IN | R1-CEP 2007-024 - Rev 03 Ramipril | Oct 2019 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | R1-CEP 2003-026 - Rev 03 Ramipril | Oct 2019 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | R1-CEP 2002-196 - Rev 04 Ramipril | Sept 2019 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Ramipril are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- India · Inactive DMF 21402 · filed Feb 2008
- RANBAXY LABORATORIES LTDInactive DMF 20380 · filed Mar 2007
- India · Inactive DMF 19719 · filed Aug 2006
- SMS Pharmaceuticals limitedIndia · Inactive DMF 17401 · filed May 2004
- ESTEVE QUIMICA SAInactive DMF 16900 · filed Oct 2003
Overview
Ramipril is an angiotensin-converting enzyme (ACE) inhibitor used primarily to treat high blood pressure and congestive heart failure. It works by relaxing blood vessels so that blood can flow more easily.
Chemical identity
- IUPAC name
- (2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid
- Canonical SMILES
- CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O
- InChIKey
- HDACQVRGBOVJII-SHCCMQHASA-N
- Synonyms
- Altace API; HOE-498
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Angiotensin Converting Enzyme Inhibitor
- Mechanism of action
- Angiotensin-converting Enzyme Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Ramipril?
17 organisations hold an active US FDA Type II Drug Master File or a CEP for Ramipril: AARTI PHARMALABS LIMITED (India), APITORIA PHARMA PRIVATE LTD (India), Cipla Limited (India), Dr. Reddy's Laboratories Ltd. (India), EUROAPI GERMANY GMBH (Germany), Hetero Labs Limited (India), Neuland Laboratories Limited (India) and Zhejiang Huahai Pharmaceutical Co., Ltd. (China), and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Ramipril Drug Master Files are active?
AARTI PHARMALABS LIMITED (DMF 19714), APITORIA PHARMA PRIVATE LTD (DMF 17570), Cipla Limited (DMF 17033), Dr. Reddy's Laboratories Ltd. (DMF 16193), EUROAPI GERMANY GMBH (DMF 15208, 37506), Hetero Labs Limited (DMF 18338), Neuland Laboratories Limited (DMF 16647) and Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 24650) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Ramipril records mean?
5 organisations have only inactive Type II DMFs for Ramipril. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Ramipril have a European Certificate of Suitability?
Yes. 14 organisations hold a valid CEP for Ramipril on the EDQM register, including ZENTIVA K.S. Prague (CZ), EGIS Pharmaceuticals PLC Budapest (HU), NEULAND LABORATORIES LIMITED Hyderabad (IN), ZHEJIANG CHANGMING PHARMACEUTICAL CO., LTD. Taizhou (CN), HETERO LABS LIMITED Hyderabad (IN) and AARTI PHARMALABS LIMITED Mulund (W), Mumbai (IN) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Ramipril supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Ramipril?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.